BackIntec Pharma Overview

Intec Pharma Selling, General & Admin

Explore Intec Pharma's selling, general & admin with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$2.02M
17.84% YoY

As of Mar 31, 2021

Annual SG&A Expenses (TTM)

$7.39M
17.16% YoY

Trailing 12 months ending Mar 31, 2021

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Intec Pharma (NTEC) FAQ

Stockcircle tracks selling, general & admin for Intec Pharma (NTEC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Intec Pharma's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main NTEC overview so you can move from this figure to the surrounding analysis quickly.